Continuous Subcutaneous Insulin Infusion (CSII) – Impact on Metabolic Control and Quality of Life of the Informal Caregiver

Authors

  • Maria Adriana Rangel Department of Pediatrics, Centro Hospitalar Vila Nova de Gaia/ Espinho
  • Carolina Baptista Department of Pediatrics, Centro Hospitalar Vila Nova de Gaia/Espinho
  • Conceição Lima Unit of Pediatric Endocrinology, Department of Pediatrics, Centro Hospitalar Vila Nova de Gaia/Espinho
  • Ana Luísa Leite Unit of Pediatric Endocrinology, Department of Pediatrics, Centro Hospitalar Vila Nova de Gaia/Espinho
  • Rosa Arménia Campos Unit of Pediatric Endocrinology, Department of Pediatrics, Centro Hospitalar Vila Nova de Gaia/Espinho

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v27.i3.13202

Keywords:

Body mass index, diabetes mellitus type 1, quality of life

Abstract

Aim: To describe the population of children treated with Continuous Insulin Subcutaneous Infusion (CSII) in a single-center unit and assess the impact on metabolic control. As an additional purpose, we also assessed the perceived burden of the caregivers of children with type 1 diabetes (T1DM) and correlated with the insulin delivery method (CSII vs. multiple daily injections - MDIs).
Methods: Descriptive, cross-sectional, observational study, of all patients with T1DM under CSII treatment, followed in a Pediatric Endocrinology Clinic between January 2011 and September 2016. Outcomes regarding metabolic control were assessed at three points: on initiation of CSII, after three to six months’ period and at the last appointment. On a second phase of our study, we applied the Informal Caregiver Burden Assessment Questionnaire, drawn and validated for the Portuguese population, to parents of children under CSII and compared them with a sample of parents of children under MDIs.
Results: Of a total of 112 T1DM patients followed, 22 patients under CSII treatment were included, with a mean HbA1c of 7.6 ± 0.9%. CSII use was associated with a reduction on body mass index (BMI) z-score over time, and no differences on HbA1C, blood pressure (BP) and lipid profile. Frequency of severe hypoglycaemia and number of hospitalization for metabolic decompensation were significantly reduced.
A total of 44 caregivers answered the questionnaire, aged between 27-52 years, the majority of the female gender (77.3%). The overall overload perceived was not high (Median [Md]=23.0%; Interquartil range [IQR]: 9.8-35.7). Emotional overload (Md=34.4%), family support (Md=25.0%) and personal life implications (Md=23.9%) were the dimensions that contributed the most to the negative overload felted. When compared between groups (n=20 CSII; n=24 MDIs), there were no differences in total or partial quotation.
Conclusion: CSII was associated with a reduction in BMI z-score, number of severe hypoglycaemia and hospitalization, with no differences in HbA1C, BP or lipid profile. Although many studies indicate an improvement in the quality of life of children with CSII and their caregivers, our study does not point to a reduction in the overload experienced. Addressing caregiver psychological distress and burden, ideally through specific and validated diabetes questionnaires, in family-based treatments such as T1DM are of valuable interest and may improve, overtime, health outcomes.

References

Sperling MT, WV, Battelino, T; Weinzimer, SA; Phillip, M. . Diabetes mellitus. In: Sperling M, editor. Pediatric Endocrinology. 4th Edition ed. Philadelphia, PA Sauders, Elsevier Inc; 2014. p. 849-93.

Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2014;15 Suppl 20:4-17.

Correia LB, JM; Fragoso de Almeida, J; Anselmo, J; Ayala, M; Cardoso, SM; Costa, AL; Dores, J; Duarte, J; Duarte, R; Ferreira, H; Medina, JL; Nunes, JS; Pereira, M; Raposo, J. Diabetes: Factos e Números – O Ano de 2015 − Relatório Anual do Observatório Nacional da Diabetes. Diabetologia SPd; 2016.

Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15 Suppl 20:115-34.

Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F, European Society for Paediatric E, et al. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30(6):1653-62.

Saúde GdSdEAed. Despacho nº 13277/2016. Diário da República: Diário da República; 2016.

Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010(1):CD005103.

Barnard KD, Lloyd CE, Skinner TC. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabet Med. 2007;24(6):607-17.

Alsaleh FM, Smith FJ, Thompson R, Al-Saleh MA, Taylor KM. Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents. Int J Clin Pharm. 2014;36(5):1023-30.

Muller-Godeffroy E, Treichel S, Wagner VM, German Working Group for Paediatric Pump T. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study. Diabet Med. 2009;26(5):493-501.

Cunningham NR, Vesco AT, Dolan LM, Hood KK. From caregiver psychological distress to adolescent glycemic control: the mediating role of perceived burden around diabetes management. J Pediatr Psychol. 2011;36(2):196-205.

Butler DA, Zuehlke JB, Tovar A, Volkening LK, Anderson BJ, Laffel LM. The impact of modifiable family factors on glycemic control among youth with type 1 diabetes. Pediatr Diabetes. 2008;9(4 Pt 2):373-81.

Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2014;15 Suppl 20:180-92.

Martins TR, JP; Garrett, C. . Estudo de Validação do Questionário de Avaliação da Sobrecarga para Cuidadores Informais. Psicologia, Saúde & Doenças. 2003;4(1):131-48.

Awadalla AW, Ohaeri JU, Al-Awadi SA, Tawfiq AM. Diabetes mellitus patients' family caregivers' subjective quality of life. J Natl Med Assoc. 2006;98(5):727-36.

Faulkner MS, Clark FS. Quality of life for parents of children and adolescents with type 1 diabetes. Diabetes Educ. 1998;24(6):721-7.

Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10(1):52-8.

Sherr JL, Hermann JM, Campbell F, Foster NC, Hofer SE, Allgrove J, et al. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia. 2016;59(1):87-91.

Szypowska A, Schwandt A, Svensson J, Shalitin S, Cardona-Hernandez R, Forsander G, et al. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry. Pediatr Diabetes. 2016;17 Suppl 23:38-45.

Barnard K, Thomas S, Royle P, Noyes K, Waugh N. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr. 2010;10:50.

Lukacs A, Kiss-Toth E, Varga B, Soos A, Takac P, Barkai L. Benefits of continuous subcutaneous insulin infusion on quality of life. Int J Technol Assess Health Care. 2013;29(1):48-52.

Cherubini V, Gesuita R, Bonfanti R, Franzese A, Frongia AP, Iafusco D, et al. Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study. Acta Diabetol. 2014;51(1):43-51.

Castelhano P. A sobrecarga dos pais enquanto cuidadores principais da criança com Espinha Bífida: Escola Superior de Enfermagem de Coimbra; 2012.

Rodrigues D. Sobrecarga e Estratégias de Coping em Cuidadores Informais de Idosos dependentes. Instituto Politécnico de Viseu, Escola Superior de Saúde de Viseu2012.

Souza LH, JS; Libera, L; Silva, VM; Mangilli, EM; Simões, PW; Ceretta, LB; Tuon, L. Overload in care, stress and impact on the quality of life of surveyed caregivers assisted in primary care. Cad Saúde Colet. 2015;23(2):140-9.

Markowitz JT, Volkening LK, Butler DA, Antisdel-Lomaglio J, Anderson BJ, Laffel LM. Re-examining a measure of diabetes-related burden in parents of young people with Type 1 diabetes: the Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR). Diabet Med. 2012;29(4):526-30.

Downloads

Published

2018-10-17

How to Cite

Rangel, M. A., Baptista, C., Lima, C., Leite, A. L., & Campos, R. A. (2018). Continuous Subcutaneous Insulin Infusion (CSII) – Impact on Metabolic Control and Quality of Life of the Informal Caregiver. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL, 27(3), 154–161. https://doi.org/10.25753/BirthGrowthMJ.v27.i3.13202

Issue

Section

Original Articles

Most read articles by the same author(s)